ArticlePharmaceuticals (Basel, Switzerland)2026
Integrated
Héctor A Baldoni, María L Sbaraglini, Darío E Balcazar, Diego G Arias, Sergio A Guerrero, Catalina D Alba Soto, Wioleta Cieslik, Marta Rogalska, Jaroslaw Polański, Ricardo D Enriz and 2 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Héctor A BaldoniFacultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco 915, San Luis 5700, Argentina.ORCID 0000-0003-2688-1697 María L SbaragliniLaboratory of Bioactive Research and Development, Medicinal Chemistry, Department of Biological Sciences, Faculty of Exact Sciences, National University of La Plata, La Plata CP1900, Argentina.ORCID 0000-0002-4671-2658 Darío E BalcazarCentro de Estudios Parasitológicos y Vectores, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Nacional de La Plata, La Plata CP1900, Argentina.
Diego G AriasLaboratorio de Enzimología Molecular, Instituto de Agrobiotecnología del Litoral, Santa Fe 3000, Argentina.
Sergio A GuerreroLaboratorio de Enzimología Molecular, Instituto de Agrobiotecnología del Litoral, Santa Fe 3000, Argentina.
Catalina D Alba SotoInstituto de Microbiología y Parasitología Médica, Departamento de Microbiología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1053, Argentina.ORCID 0000-0002-2724-0421 Wioleta CieslikInstitute of Chemistry, University of Silesia, 75 Pułku Piechoty 1a, 41-500 Chorzow, Poland.ORCID 0000-0001-6371-9061 Marta RogalskaInstitute of Chemistry, University of Silesia, 75 Pułku Piechoty 1a, 41-500 Chorzow, Poland.ORCID 0000-0002-3411-5143 Jaroslaw PolańskiInstitute of Chemistry, University of Silesia, 75 Pułku Piechoty 1a, 41-500 Chorzow, Poland.ORCID 0000-0001-7361-2671 Ricardo D EnrizFacultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco 915, San Luis 5700, Argentina.
Robert MusiolInstitute of Chemistry, University of Silesia, 75 Pułku Piechoty 1a, 41-500 Chorzow, Poland.ORCID 0000-0002-6219-7369 Funding
National Science Centre 2018/31/B/NZ7/02122Slovak Research and Development Agency APVV-22-0133
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antitrypanosomal activitycruzipain inhibitionpiperazinyl thiosemicarbazonesstructure-activity relationshipsTrypanosoma cruzi
Identifiers
PMID41599779
PMCPMC12845152
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390